The Impact of Radiological Response to Peptide Receptor Radionuclide Therapy on Overall Survival in Patients With Metastatic Midgut Neuroendocrine Tumors

Yalchin Mehmet; Oliveira Amelia; Theocharidou Eleni; Pencharz Deborah; Navalkissoor Shaunak; Quigley Ann-Marie; Walker Martin; Caplin Martyn; Toumpanakis Christos

首页> 外文期刊>Clinical nuclear medicine >The Impact of Radiological Response to Peptide Receptor Radionuclide Therapy on Overall Survival in Patients With Metastatic Midgut Neuroendocrine Tumors

【24h】

The Impact of Radiological Response to Peptide Receptor Radionuclide Therapy on Overall Survival in Patients With Metastatic Midgut Neuroendocrine Tumors

机译：放射性反应对肽受体放射性核素治疗对转移粒细胞神经内分泌肿瘤患者总生存的影响

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose of the Report: Peptide receptor radionuclide therapy (PRRT) is an effective treatment for advanced neuroendocrine tumors (NET); however, long-term survival data are scarce. The aim of this study is to determine long-term survival in patients with metastatic midgut NET, according to response to PRRT.

机译：报告的目的：肽受体放射性核素治疗（PRRT）是针对先进神经内分泌肿瘤（净）的有效治疗; 然而，长期生存数据是稀缺的。该研究的目的是根据对PRRT的反应确定转移型矿物网患者的长期存活。

著录项

来源
《Clinical nuclear medicine 》 |2017年第3期| 共7页
作者
Yalchin Mehmet; Oliveira Amelia; Theocharidou Eleni; Pencharz Deborah; Navalkissoor Shaunak; Quigley Ann-Marie; Walker Martin; Caplin Martyn; Toumpanakis Christos;
展开▼
作者单位

Royal Free Hosp ENETS Ctr Excellence Neuroendocrine Tumour Unit London England;

Univ Coll London Hosp Care Elderly London England;

Royal Free Hosp ENETS Ctr Excellence Neuroendocrine Tumour Unit London England;

Univ Coll London Hosp Care Elderly London England;

Royal Free Hosp Dept Nucl Med London England;

Royal Free Hosp Dept Nucl Med London England;

Imperial Coll London Fac Med St Marys Campus London England;

Royal Free Hosp ENETS Ctr Excellence Neuroendocrine Tumour Unit London England;

Royal Free Hosp ENETS Ctr Excellence Neuroendocrine Tumour Unit London England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学 ;
关键词
midgut neuroendocrine tumors; peptide receptor radionuclide therapy; overall survival; progression-free survival;

机译：胚胎神经内分泌肿瘤;肽受体放射性核素治疗;整体存活;无进展生存;

相似文献

外文文献
中文文献
专利

1. The Impact of Radiological Response to Peptide Receptor Radionuclide Therapy on Overall Survival in Patients With Metastatic Midgut Neuroendocrine Tumors [J] . Yalchin Mehmet, Oliveira Amelia, Theocharidou Eleni, Clinical nuclear medicine . 2017 ,第3期

机译：放射性反应对肽受体放射性核素治疗对转移粒细胞神经内分泌肿瘤患者总生存的影响
2. Survival and response after peptide receptor radionuclide therapy with (90Y-DOTA0,Tyr3)octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors. [J] . Valkema R, Pauwels S, Kvols LK, Seminars in Nuclear Medicine . 2006 ,第2期

机译：（90Y-DOTA0，Tyr3）奥曲肽肽受体放射性核素治疗晚期胃肠道胰腺神经内分泌肿瘤患者的生存和应答
3. Peptide receptor radionuclide therapy with 90Y-DOTATATE|[sol]|90Y-DOTATOC in patients with progressive metastatic neuroendocrine tumours: assessment of response, survival and toxicity [J] . S Vinjamuri, T M Gilbert, M Banks, British Journal of Cancer . 2013 ,第7期

机译：90Y-DOTATATE | [sol] | 90Y-DOTATOC进行的肽受体放射性核素治疗进行性转移性神经内分泌肿瘤的患者：评估疗效，生存率和毒性
4. ~(213)Bi-DOTATOC receptor targeted alpha-radionuclide therapy induces remission in neuroendocrine tumors refractory to beta-radiation - a first in human study [C] . Giesel FL, Kratochwil C, Bruchertseifer F, 8th International Conference on Isotopes 2014 . 2014

机译：〜（213）Bi-DOTATOC受体靶向的α-放射性核素疗法可诱导难于β辐射的神经内分泌肿瘤缓解-这是人类研究中的首次
5. Associating Computed Tomography (CT) Imaging Response Criteria and Texture Analysis Measurements with Survival in Patients with Metastatic Melanoma Treated with Anti-angiogenic Therapy. [D] . Gray, Mark Russell. 2014

机译：将计算机断层扫描（CT）成像反应标准和纹理分析测量值与接受抗血管生成治疗的转移性黑色素瘤患者的生存率相关联。
6. Peptide receptor radionuclide therapy with 90Y-DOTATATE/90Y-DOTATOC in patients with progressive metastatic neuroendocrine tumours: assessment of response survival and toxicity [O] . S Vinjamuri, T M Gilbert, M Banks, 2013

机译：进行性转移性神经内分泌肿瘤患者的90Y-DOTATATE / 90Y-DOTATOC肽受体放射性核素治疗：评估疗效生存率和毒性
7. Peptide receptor radionuclide therapy with 90Y-DOTATATE/90Y-DOTATOC in patients with progressive metastatic neuroendocrine tumours: assessment of response, survival and toxicity [O] . S Vinjamuri, T M Gilbert, M Banks, 2013

机译：肽受体放射性核素疗法治疗90大致乳酸/ 90Y-丁香患者患者进行渐进式后神经内分泌肿瘤：对响应，存活和毒性的评估

The Impact of Radiological Response to Peptide Receptor Radionuclide Therapy on Overall Survival in Patients With Metastatic Midgut Neuroendocrine Tumors

摘要

著录项

相似文献

相关主题

期刊订阅